Measures of Physical Performance and Muscle Strength as Predictors of Fracture Risk Independent of FRAX, Falls, and aBMD: A Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) Study
- PMID: 30011086
- PMCID: PMC6272117
- DOI: 10.1002/jbmr.3556
Measures of Physical Performance and Muscle Strength as Predictors of Fracture Risk Independent of FRAX, Falls, and aBMD: A Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) Study
Abstract
Measures of muscle mass, strength, and function predict risk of incident fractures, but it is not known whether this risk information is additive to that from FRAX (fracture risk assessment tool) probability. In the Osteoporotic Fractures in Men (MrOS) Study cohorts (Sweden, Hong Kong, United States), we investigated whether measures of physical performance/appendicular lean mass (ALM) by DXA predicted incident fractures in older men, independently of FRAX probability. Baseline information included falls history, clinical risk factors for falls and fractures, femoral neck aBMD, and calculated FRAX probabilities. An extension of Poisson regression was used to investigate the relationship between time for five chair stands, walking speed over a 6 m distance, grip strength, ALM adjusted for body size (ALM/height2 ), FRAX probability (major osteoporotic fracture [MOF]) with or without femoral neck aBMD, available in a subset of n = 7531), and incident MOF (hip, clinical vertebral, wrist, or proximal humerus). Associations were adjusted for age and time since baseline, and are reported as hazard ratios (HRs) for first incident fracture per SD increment in predictor using meta-analysis. 5660 men in the United States (mean age 73.5 years), 2764 men in Sweden (75.4 years), and 1987 men in Hong Kong (72.4 years) were studied. Mean follow-up time was 8.7 to 10.9 years. Greater time for five chair stands was associated with greater risk of MOF (HR 1.26; 95% CI, 1.19 to 1.34), whereas greater walking speed (HR 0.85; 95% CI, 0.79 to 0.90), grip strength (HR 0.77; 95% CI, 0.72 to 0.82), and ALM/height2 (HR 0.85; 95% CI, 0.80 to 0.90) were associated with lower risk of incident MOF. Associations remained largely similar after adjustment for FRAX, but associations between ALM/height2 and MOF were weakened (HR 0.92; 95% CI, 0.85 to 0.99). Inclusion of femoral neck aBMD markedly attenuated the association between ALM/height2 and MOF (HR 1.02; 95% CI, 0.96 to 1.10). Measures of physical performance predicted incident fractures independently of FRAX probability. Whilst the predictive value of ALM/height2 was substantially reduced by inclusion of aBMD requires further study, these findings support the consideration of physical performance in fracture risk assessment. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
Keywords: EPIDEMIOLOGY; FALLS; FRACTURE; FRAX; INTERACTION; OSTEOPOROSIS.
© 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
Figures
References
-
- Masud T, Morris RO. Epidemiology of falls. Age and ageing. 2001. Nov; 30 Suppl 4:3–7. Epub 2002 Jan 5. - PubMed
-
- Masud T, Binkley N, Boonen S, Hannan MT. Official positions for FRAX(R) clinical regarding falls and frailty: can falls and frailty be used in FRAX(R)? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R). J Clin Densitom. 2011. Jul–Sep; 14(3):194–204. Epub 2011 Aug 4. - PubMed
Publication types
MeSH terms
Grants and funding
- 17702/VAC_/Versus Arthritis/United Kingdom
- MC_U147585827/MRC_/Medical Research Council/United Kingdom
- 21231/VAC_/Versus Arthritis/United Kingdom
- UL1 TR000128/TR/NCATS NIH HHS/United States
- UL1 TR002369/TR/NCATS NIH HHS/United States
- 21231/ARC_/Arthritis Research UK/United Kingdom
- MC_UP_A620_1014/MRC_/Medical Research Council/United Kingdom
- U01 AG042168/AG/NIA NIH HHS/United States
- U01 AG042140/AG/NIA NIH HHS/United States
- MC_UU_12011/1/MRC_/Medical Research Council/United Kingdom
- MR/P020941/1/MRC_/Medical Research Council/United Kingdom
- G0400491/MRC_/Medical Research Council/United Kingdom
- U01 AG042139/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- MC_U147585819/MRC_/Medical Research Council/United Kingdom
- U01 AG042124/AG/NIA NIH HHS/United States
- 17702/ARC_/Arthritis Research UK/United Kingdom
- U01 AG042145/AG/NIA NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- HTA/10/33/04/DH_/Department of Health/United Kingdom
- MC_U147585824/MRC_/Medical Research Council/United Kingdom
- U01 AG042143/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
